Three early signs of what it looks like to put P.O.W.E.R into practice.
The LYMA P.O.W.E.R Index: Proven, Outcomes, Whole-System, Empowering, Return - is the world’s first health ROI framework, built on the same logic as a credit rating for a bond. It’s a new way to judge whether a health purchase is a sound investment or just an expensive, and unnecessary, spend.
What follows is the future of women’s health, already taking shape: three early signs of what it looks like to put P.O.W.E.R into practice.
For decades, women’s healthcare has worked in single appointments. A symptom leads to a visit, the visit ends, and the details reset until the next one starts. That works fine for problems that stay in one place. It doesn’t work as well for a body where very little happens in isolation.
That’s now changing in three areas. Concierge medicine is turning care into an ongoing relationship, rather than a one-off appointment. Wearable devices and at-home tests are turning diagnosis into something checked every day, instead of once a year. And a growing number of brands now back up their claims with real evidence - the kind a scientific journal would require, rather than marketing language alone. Measured against the LYMA Power Index, three letters matter most across all three: Proven, Outcomes and Empowering.
The health concierge: care that never resets to zero
Treating symptoms in isolation has a real cost. New research from The Menopause Society found that confusion about symptoms causes 56% of delayed perimenopause diagnoses, and a further 28% comes down to gaps in knowledge, leaving women to research their own symptoms. Both problems come from the same place: no single appointment carries the full picture forward.
Concierge medicine is designed to fix that. Silicon Valley gynaecologist Dr Sally Greenwald has built her practice around ongoing care rather than one-off visits, combining menopause medicine, hormone treatment and sexual health with direct, continuous access to her expertise. That way, a new symptom is read alongside everything that came before it, instead of being treated as a standalone event.
SOLICE in London works on the same idea, but wider: it combines concierge medicine, precision diagnostics and longevity programmes into one membership, where prevention and continuity matter as much as clinical expertise.
What both are offering is not a single appointment, but an ongoing relationship.
“The issue with conventional medicine is it’s all reactive, not proactive. For years, I would change the term ‘prevention’ to ‘proactive medicine.’”
Dr Florence Comite, endocrinologist, founder of the Comite Center for Precision Medicine & Healthy Longevity
That’s the Outcomes and Empowering side of P.O.W.E.R in practice: not just treating what’s already gone wrong, but staying involved long enough to act on it early.
Continuous diagnostics: checking in every day, not once a year
Diagnosis, too, is moving out of the clinic altogether. Health data that once needed a lab visit and a wait for results can now be collected at any time, through a device on your wrist or a test on your kitchen counter. What used to be a single snapshot is becoming an ongoing stream of information.
Neko Health applies this idea to full-body screening. Its scan takes just 15 minutes and checks more than 50 health markers at once - the kind of coverage that once meant several separate clinic visits, condensed into something fast, accurate and easy to fit into an ordinary day.
Tally Health, based in New York and founded by Whitney Casey and David Sinclair, goes a step further: a simple cheek swab, taken every few months from the comfort of home, turns into an ongoing measure of biological ageing with personalised advice on diet, fitness and mental health attached. Diagnosis becomes something you subscribe to, not something you do once.
Clair Health, which launched from Stanford University in November 2026, takes this even further: a wrist-worn device with ten sensors and AI that estimates oestrogen, progesterone and the hormones that control ovulation, in real time. Built around what its founders call “life-stage intelligence,” it tracks a woman’s hormones as they actually behave - changing day-to-day, rather than relying on a single blood test taken once a year and treated as accurate until the next one.
What a lab test could once only tell you after the fact, these tools now show as it happens. A woman no longer has to wait for a doctor to tell her how her hormones, sleep or biological age are tracking - she has that information herself, updated daily, and can act on it straight away. That’s the Whole-System and Empowering parts of P.O.W.E.R at work: seeing the body as one connected system, and having the day-to-day information to make decisions about it herself, rather than relying on someone else to interpret it for her.
The science standard: proof becomes the product
None of this works without proof. A concierge doctor or a daily hormone reading can point a woman toward a treatment, a supplement or a protocol, but that recommendation is only as good as the evidence sitting behind it.
Consumers are already holding products to that standard themselves: eight in ten now say they always check the ingredients before buying a new beauty or wellness product, and 72% think the industry spends more energy launching the next exciting product than proving its existing ones actually work. People haven’t lost interest in staying healthy for longer. They’ve lost patience with claims that sound like proof but aren’t.
LYMA’s Laser was built to answer that scepticism head-on. It holds 38 global patents, including a double-diffused lens that delivers more energy into the skin than other devices on the market, so the technology backs up its own claims rather than just making them.
Just as importantly, it’s designed to support skin health over the long term, rather than relying on the kind of controlled damage many aesthetic treatments use to trigger repair. Its clinical trials, published in the Aesthetic Surgery Journal in 2025, recorded a 103% increase in skin elasticity in just 30 days - a record result for a clinically tested skin treatment.
The same standard has since moved from the device into skincare. In July 2026, LYMA brought its Genolytic™ technology into a hydrating serum. A clinical study recorded a 71% increase in skin hydration over 28 days, continuing the same approach: proving a product works through measurement, not just describing it.
As Dr Stephanie Kuku, surgical oncologist and Chief Regulatory & Science Affairs Officer at Conceivable Life Sciences, points out, this also marks a shift in who is doing the research.
“Twenty years ago, scientific discovery largely belonged to universities and pharmaceutical companies. Today, some of the most ambitious research into ageing, skin biology and prevention is being driven by consumer health and beauty companies themselves. That’s fundamentally changing where innovation comes from.”
Dr Stephanie Kuku
The common thread
These three shifts aren’t separate stories. A concierge relationship, a wearable sensor, and a peer-reviewed elasticity result are all answering the same question the Power Index asks of any health decision: not just does it work, but can it prove it, does that proof hold up to real scrutiny, and does it leave a woman better equipped to understand her own health than before.
That’s what the future of women’s health looks like: not another product to take on faith, but a standard, finally, worth investing in.
See the standard in practice
This is the proof standard behind LYMA Laser itself. Discover LYMA Laser Starter Kit now.
